[HTML][HTML] COVID-19 vaccination response and its practical application in patients with chronic lymphocytic leukemia
M Shadman, C Liu, K Eakle, HJ Hiew, JML Biondo… - …, 2023 - journals.lww.com
Patients with chronic lymphocyticleukemia (CLL) typically have innate/adaptive immune
system dysregulation, thus the protective effect of coronavirus disease 2019 (COVID-19) …
system dysregulation, thus the protective effect of coronavirus disease 2019 (COVID-19) …
Real-world safety of emicizumab: interim analysis of the European haemophilia safety surveillance (EUHASS) database
F Nissen, Y Jiang, HJ Hiew, M Aizenas, G Tobaruela… - Blood, 2022 - ashpublications.org
Background: European Haemophilia Safety Surveillance (EUHASS) is an investigator-led
pharmacovigilance program collecting real-world safety data on treatments for inherited …
pharmacovigilance program collecting real-world safety data on treatments for inherited …
Efficacy of High and Low Dose Oral Vitamin D Replacement Therapy in Inflammatory Bowel Disease (Ibd): Single Centre Cohort
HJ Hiew, M Naghibi, J Wu, J Saunders, F Cummings… - Gut, 2013 - search.proquest.com
Method All IBD patients with serum vitamin D levels measured in 2011 were identified.
Vitamin D deficiency was determined as plasma 25-hydroxyvitamin D levels< 52 nmol/L …
Vitamin D deficiency was determined as plasma 25-hydroxyvitamin D levels< 52 nmol/L …
[HTML][HTML] Successful treatment of chronic myelomonocytic leukaemia with hydroxycarbamide in a patient presenting with acute hypoxic respiratory failure due to COVID …
J Chopra, HJ Hiew, A Cumpstey… - British Journal of …, 2020 - ncbi.nlm.nih.gov
Discussion Here we report the first case where COVID‐19 unexpectedly presented
concurrently with an underlying haematological malignancy, with profound hypoxaemia …
concurrently with an underlying haematological malignancy, with profound hypoxaemia …
Characteristics and Bleeding Behavior of Females with Mild Hemophilia A: Longitudinal Study from Picnichealth Hemophilia A Database
AC Weyand, HJ Hiew, Y Jiang, A Siadimas, F Nissen… - Blood, 2022 - ashpublications.org
Background: Hemophilia A (HA) is an X-linked condition characterized by factor VIII (FVIII)
levels below the normal range, leading to excessive bleeding. Disease severity can be …
levels below the normal range, leading to excessive bleeding. Disease severity can be …
Characteristics and Healthcare Utilization of Patients with Mild or Moderate Hemophilia A in the US-an Analysis from the Picnichealth Cohort
A Sharathkumar, Y Jiang, HJ Hiew, A Siadimas… - Blood, 2022 - ashpublications.org
Background: People with mild or moderate hemophilia A (HA) constitute 40-52% of all
people with HA; nonetheless, they are a poorly characterized population in real-world data …
people with HA; nonetheless, they are a poorly characterized population in real-world data …
Characterizing Diffuse Large B Cell Lymphoma (DLBCL) Disease Biology Features and Survival Outcomes By Patient Racial Groups Using Real World Data
HJ Hiew, Y Liu, S James, S Balasubramanian… - Blood, 2022 - ashpublications.org
Background Various real world data (RWD) studies have highlighted differences in the
survival outcomes of DLBCL patients of different ethnicities and racial groups. However, few …
survival outcomes of DLBCL patients of different ethnicities and racial groups. However, few …
[HTML][HTML] P1268: DELINEATING THE NEOANTIGEN BURDEN AND TUMOUR MICROENVIRONMENT IN PATIENTS WITH DIFFUSE LARGE B CELL LYMPHOMA …
Y Jiang, D Jin, C Henneges, E Penuel, HJ Hiew… - …, 2022 - journals.lww.com
Background: DLBCL is a heterogeneous neoplasm classified into 2 main cell-of-origin
(COO) subtypes; activated B cell (ABC) and germinal centre B cell (GCB), with ABC having a …
(COO) subtypes; activated B cell (ABC) and germinal centre B cell (GCB), with ABC having a …
PTU-078 Efficacy of High and low dose Oral Vitamin D Replacement Therapy in Inflammatory Bowel Disease: Single Centre Cohort
HJ Hiew, M Naghibi, J Wu, J Saunders, F Cummings… - Gut, 2013 - gut.bmj.com
Introduction Inflammatory bowel disease (IBD) patients are at risk of micronutrient
deficiencies, including vitamin D. There is increasing evidence that vitamin D deficiency has …
deficiencies, including vitamin D. There is increasing evidence that vitamin D deficiency has …
[CITATION][C] P304 Two year study of high and low dose oral vitamin D replacement therapy in adult inflammatory bowel disease
M Naghibi, HJ Hiew, J Saunders… - Journal of Crohn's and …, 2014 - infona.pl
P304 Two year study of high and low dose oral vitamin D replacement therapy in adult
inflammatory bowel disease × Close The Infona portal uses cookies, ie strings of text saved by …
inflammatory bowel disease × Close The Infona portal uses cookies, ie strings of text saved by …